MET and non-small cell lung carcinoma: To demonstrate the specificity of Plk1 inhibitors, we knocked down PLK1 and MET expression in NSCLC cell lines using siRNA for 48 h (Fig 4A) and observed a significant increase in apoptosis compared with non‐targeting control and single‐gene silencing (Fig 4F).